TY - JOUR
T1 - Signaling from the membrane via membrane estrogen receptor-α
T2 - Estrogens, xenoestrogens, and phytoestrogens
AU - Watson, Cheryl S.
AU - Bulayeva, Nataliya N.
AU - Wozniak, Ann L.
AU - Finnerty, Celeste C.
N1 - Funding Information:
Our studies were supported by NIEHS grant #010987 and the Sealy Memorial Endowment Fund. We thank Dr. David Konkel for critical reading of our manuscript.
PY - 2005
Y1 - 2005
N2 - Estrogen mimetics in the environment and in foods can have important consequences for endocrine functions. When previously examined for action via genomic steroid signaling mechanisms, most of these compounds were found to be very weak agonists. We have instead tested their actions via several membrane-initiated signaling mechanisms in GH3/B6 pituitary tumor cells extensively selected for high (responsive) or low (nonresponsive) expression of the membrane version of estrogen receptor-α (mERα). We found many estrogen mimetic compounds to be potently active in our quantitative extracellular-regulated kinase (ERK) activation assays, to increase cellular Ca++ levels, and to cause rapid prolactin release. However, these compounds may activate one or both mechanisms with different potencies. For instance, some compounds activate ERKs in both pM and nM concentration ranges, while others are only active at nM and higher concentrations. Compounds also show great differences in their temporal activation patterns. While estradiol causes a bimodal time-dependent ERK activation (peaking at both 3 and 30 min), most estrogen mimetics cause either an early phase activation, a late phase activation, or an early sustained activation. One xenoestrogen known to be a relatively potent activator of estrogen response element-mediated actions (bisphenol A) is inactive as an ERK activator, and only a modest inducer of Ca++ levels and prolactin release. Many different signaling machineries culminate in ERK activation, and xenoestrogens differentially affect various pathways. Clearly individual xenoestrogens must be individually investigated for their differing abilities to activate distinct membrane-initiated signal cascades that lead to a variety of cellular functions.
AB - Estrogen mimetics in the environment and in foods can have important consequences for endocrine functions. When previously examined for action via genomic steroid signaling mechanisms, most of these compounds were found to be very weak agonists. We have instead tested their actions via several membrane-initiated signaling mechanisms in GH3/B6 pituitary tumor cells extensively selected for high (responsive) or low (nonresponsive) expression of the membrane version of estrogen receptor-α (mERα). We found many estrogen mimetic compounds to be potently active in our quantitative extracellular-regulated kinase (ERK) activation assays, to increase cellular Ca++ levels, and to cause rapid prolactin release. However, these compounds may activate one or both mechanisms with different potencies. For instance, some compounds activate ERKs in both pM and nM concentration ranges, while others are only active at nM and higher concentrations. Compounds also show great differences in their temporal activation patterns. While estradiol causes a bimodal time-dependent ERK activation (peaking at both 3 and 30 min), most estrogen mimetics cause either an early phase activation, a late phase activation, or an early sustained activation. One xenoestrogen known to be a relatively potent activator of estrogen response element-mediated actions (bisphenol A) is inactive as an ERK activator, and only a modest inducer of Ca++ levels and prolactin release. Many different signaling machineries culminate in ERK activation, and xenoestrogens differentially affect various pathways. Clearly individual xenoestrogens must be individually investigated for their differing abilities to activate distinct membrane-initiated signal cascades that lead to a variety of cellular functions.
KW - Estradiol
KW - Mechanism of action
KW - Nongenomic
KW - Steroid action
UR - http://www.scopus.com/inward/record.url?scp=18144406916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18144406916&partnerID=8YFLogxK
U2 - 10.1016/j.steroids.2005.03.002
DO - 10.1016/j.steroids.2005.03.002
M3 - Article
C2 - 15862819
AN - SCOPUS:18144406916
SN - 0039-128X
VL - 70
SP - 364
EP - 371
JO - Steroids
JF - Steroids
IS - 5-7 SPEC. ISS.
ER -